Wang, Shun-Xin
Yang, Yi
Xie, Hui
Yang, Xin
Liu, Zhi-Qiao
Li, Hao-Jiang
Huang, Wen-Jie
Luo, Wei-Jie
Lei, Yi-Ming
Sun, Ying
Ma, Jun
Chen, Yan-Feng
Liu, Li-Zhi
Mao, Yan-Ping http://orcid.org/0000-0003-1027-071X
Funding for this research was provided by:
National Natural Science Foundation of China (82272740)
Sun Yat-Sen University Clinical Research 5010 Program (2020-FXY-406)
Article History
Received: 9 November 2023
Revised: 13 January 2024
Accepted: 7 February 2024
First Online: 22 March 2024
Declarations
:
: The scientific guarantor of this publication is Yan-Ping Mao.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors (Shun-Xin Wang, Sun Yat-sen University Cancer Center) who has significant statistical expertise performed all statistical analyses. The key raw data underlying this study were uploaded to the Research Data Deposit public platform (RDDA2024775288). Reasonable requests for data sharing should be made to the corresponding author and will be handled in line with the data access and sharing policy of Human Genetic Resource Administration of China and other participating sites outside of China.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained. The institutional ethics committee of Sun Yat-sen University Cancer Center approved this study.
: The whole study cohort has been reported in our previous study [Luo et al Radiother Oncol 2021], but the difference is that the current study applied radiomics to establish a predictive model and assist clinical decision-making for locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
: • retrospective• observational• performed at one institution